CHICAGO, July 27 (Reuters) – TauRx Pharmaceuticals’
experimental Alzheimer’s drug LMTX failed to improve cognitive
and functional skills in patients with mild to moderate
Alzheimer’s disease, a…
The post UPDATE 1-TauRx Alzheimer’s drug fails in large study; some benefit seen appeared first on NASDAQ.